Global Human Milk Oligosaccharides Market Expected to Grow with a CAGR of 21% During the Forecast Period, 2018-2027 -

DUBLIN--()--The "Human Milk Oligosaccharides - Global Market Outlook (2018-2027)" report has been added to's offering.

The Global Human Milk Oligosaccharides Market accounted for $17.90 million in 2018 and is expected to reach $98.05 million by 2027 growing at a CAGR of 21%.

Growing application of HMOs in functional foods and increasing demand in infant formula is likely to boost the growth of the market. However, the high cost of production is hindering the growth of the global human milk oligosaccharides market is likely to hamper the profit boundaries.

Human milk oligosaccharides (HMOs) act as prebiotics in human body and help in maintaining gut health. They promote bacterial growth, especially bifidobacteria genus, in the gut, which helps in improving metabolic activity. The antimicrobial protection and prebiotic functions of the product allow them to be used in various food products including pharmaceutical and medicinal food and infant formulas.

Based on the application, the infant formulas are anticipated to grow at the fastest rate during the forecast period. This is attributable to the health benefits associated with the infant formulas such as maintaining gut microbiota and inhibition of pathogen in infants.

By geography, North America recorded the largest share of the global human milk oligosaccharides market revenues. The presence of several major infant formula and baby food manufacturers and technological advancements in the region can be considered major factors driving the market growth.

What the report offers:

  • Market share assessments for the regional and country level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2017, 2018, 2019, 2023 and 2027
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic analysis: Drivers and Constraints, Product/Technology Analysis, Porter's five forces analysis, SWOT analysis etc.
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Key Topics Covered:

1 Executive Summary

2 Preface

2.1 Abstract

2.2 Stake Holders

2.3 Research Scope

2.4 Research Methodology

2.4.1 Data Mining

2.4.2 Data Analysis

2.4.3 Data Validation

2.4.4 Research Approach

2.5 Research Sources

2.5.1 Primary Research Sources

2.5.2 Secondary Research Sources

2.5.3 Assumptions

3 Market Trend Analysis

3.1 Introduction

3.2 Drivers

3.3 Restraints

3.4 Opportunities

3.5 Threats

3.6 Product Analysis

3.7 Application Analysis

3.8 Emerging Markets

3.9 Futuristic Market Scenario

4 Porters Five Force Analysis

4.1 Bargaining power of suppliers

4.2 Bargaining power of buyers

4.3 Threat of substitutes

4.4 Threat of new entrants

4.5 Competitive rivalry

5 Global Human Milk Oligosaccharides Market, By Product

5.1 Introduction

5.2 Sialyllactose (6'SL)

5.3 Sialyllactose (3'SL)

5.4 Lacto-N-tetraose (LNT)

5.5 Lacto-N-neotetraose (LNnT)

5.6 Fucosyllactose (3'FL)

5.7 Fucosyllactose (2'FL)

6 Global Human Milk Oligosaccharides Market, By Applications

6.1 Introduction

6.2 Functional Food & Beverages

6.3 Food Supplements

6.4 Infant Formula

6.5 Health Ingredients for Human and Animal

6.6 Other Applications

7 Global Human Milk Oligosaccharides Market, By Geography

7.1 Introduction

7.2 North America

7.2.1 US

7.2.2 Canada

7.2.3 Mexico

7.3 Europe

7.3.1 Germany

7.3.2 UK

7.3.3 Italy

7.3.4 France

7.3.5 Spain

7.3.6 Rest of Europe

7.4 Asia Pacific

7.4.1 Japan

7.4.2 China

7.4.3 India

7.4.4 Australia

7.4.5 New Zealand

7.4.6 South Korea

7.4.7 Rest of Asia Pacific

7.5 South America

7.5.1 Argentina

7.5.2 Brazil

7.5.3 Chile

7.5.4 Rest of South America

7.6 Middle East & Africa

7.6.1 Saudi Arabia

7.6.2 UAE

7.6.3 Qatar

7.6.4 South Africa

7.6.5 Rest of Middle East & Africa

8 Key Developments

8.1 Agreements, Partnerships, Collaborations and Joint Ventures

8.2 Acquisitions & Mergers

8.3 New Product Launch

8.4 Expansions

8.5 Other Key Strategies

9 Company Profiling

9.1 ZuChem Inc

9.2 Medolac Laboratories

9.3 Jennewein Biotechnologie GmbH

9.4 Inbiose NV

9.5 Glycosyn LLC

9.6 Glycom A/S

9.7 Elicityl S A

For more information about this report visit

Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900